MENLO PARK, Calif., March 18, 2026 (GLOBE NEWSWIRE) -- PacBio (PACB), a leading provider of high-quality, long-read sequencing technologies, today announced that Basecamp Research, a frontier AI lab ...
SAN FRANCISCO / ACCESSWIRE / June 27, 2024 / Form Bio, the provider of advanced computational life sciences technology and PacBio (NASDAQ:PACB), a leading developer of high-quality, highly accurate ...
Zacks Investment Research on MSN
PacBio & Lucid Genomics partner to boost data analysis, stock up
PacBio PACB recently announced a compatibility collaboration with Lucid Genomics, bringing the latter into its Compatible ...
MENLO PARK, Calif., Jan. 12, 2026 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB), developer of the world's most advanced sequencing technologies, today announced plans to pursue a strategic collaboration ...
PacBio, a leading developer of high-quality, highly accurate sequencing solutions today announced a clinical research study with Radboud University Medical Center (Radboudumc) to explore genetic ...
Zacks Investment Research on MSN
PacBio stock up on new FFPE workflow boosting cancer sequencing
PacBio PACB recently announced a new joint workflow with Covaris, a PerkinElmer company and leader in sample preparation ...
PacBio, a leading developer of high-quality, highly accurate sequencing solutions, today announced that Bioscientia is using its Revio long-read sequencing system to expand its genomics research ...
PacBio’s Revio system and SPRQ-Nx chemistry to enable an order-of-magnitude expansion of HiFi metagenomic sequencing for scaling AI-designed therapeutics MENLO PARK, Calif., March 18, 2026 (GLOBE ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results